Advanced search
Publication Cover
Patient Preference and Adherence Volume 4, 2010 - Issue
Submit an article Journal homepage
81
Views
7
CrossRef citations to date
0
Altmetric
Original Research

Modeling the economic impact of medication adherence in type 2 diabetes: a theoretical approach

David S Cobden1 Department of Health Policy and Management, Section of Health Economics – Medical Technology Assessment (HE-MTA), Erasmus MC, Erasmus University Rotterdam, The NetherlandsCorrespondence[email protected]
,
Louis W Niessen2 Department of International Health, Johns Hopkins University School of Public Health, Johns Hopkins Medical Institutions, Baltimore, MD, USA
,
Frans FH Rutten1 Department of Health Policy and Management, Section of Health Economics – Medical Technology Assessment (HE-MTA), Erasmus MC, Erasmus University Rotterdam, The Netherlands
&
W Ken Redekop1 Department of Health Policy and Management, Section of Health Economics – Medical Technology Assessment (HE-MTA), Erasmus MC, Erasmus University Rotterdam, The Netherlands
Pages 283-290 | Published online: 10 Aug 2010

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Xin Wang, Hua Chen, Essien E, Jun Wu, Omar Serna, Rutugandha Paranjpe & Susan Abughosh. (2021) Cost-effectiveness analysis of antihypertensive triple combination therapy among patients enrolled in a Medicare advantage plan. Expert Review of Pharmacoeconomics & Outcomes Research 21:4, pages 829-836.
Read now
Saeideh Mirghorbani, Sharif Melouk & John Mittenthal. (2021) The effect of adherence on antihypertensive therapy plans in patients with diabetes. IISE Transactions on Healthcare Systems Engineering 11:2, pages 95-112.
Read now
Mingsheng Chen, Lei Si, Tania M Winzenberg, Jieruo Gu, Qicheng Jiang & Andrew J Palmer. (2016) Cost-effectiveness of raloxifene in the treatment of osteoporosis in Chinese postmenopausal women: impact of medication persistence and adherence. Patient Preference and Adherence 10, pages 415-423.
Read now
Ronan Roussel, Luc Martinez, Tom Vandebrouck, Habiba Douik, Patrick Emiel, Matthieu Guery, Barnaby Hunt & William J. Valentine. (2016) Evaluation of the long-term cost-effectiveness of liraglutide therapy for patients with type 2 diabetes in France. Journal of Medical Economics 19:2, pages 131-144.
Read now

Articles from other publishers (3)

Fransiskus Samuel Renaldi, Rani Sauriasari & Woro Riyadina. (2021) Pandemic 2020: Economic pressure and evaluation of a primary health care innovation programme for type 2 diabetes mellitus treatment. Pharmacy Education 21:2, pages 132-142.
Crossref
Karen R. Siegel, Mohammed K. Ali, Xilin Zhou, Boon Peng Ng, Shawn Jawanda, Krista Proia, Xuanping Zhang, Edward W. Gregg, Ann L. Albright & Ping Zhang. (2020) Cost-effectiveness of Interventions to Manage Diabetes: Has the Evidence Changed Since 2008?. Diabetes Care 43:7, pages 1557-1592.
Crossref
Patrick M. Zueger, Neil M. Schultz & Todd A. Lee. (2014) Cost Effectiveness of Liraglutide in Type II Diabetes: A Systematic Review. PharmacoEconomics 32:11, pages 1079-1091.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.